![]() |
市場調查報告書
商品編碼
1965311
造口護理市場-全球產業規模、佔有率、趨勢、機會與預測:按產品、應用、最終用戶、地區和競爭對手分類,2021-2031年Stoma Care Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球造口護理市場預計將從 2025 年的 6.7243 億美元成長到 2031 年的 10.0687 億美元,複合年成長率為 6.96%。
該市場涵蓋用於管理接受造造口手術患者的排泄物的醫療設備(例如造口口袋和皮膚保護劑)。推動該市場發展的關鍵因素包括大腸直腸癌和發炎性腸道疾病發生率的上升,以及人口老化導致的外科手術需求增加。根據美國癌症協會 (ACS) 估計,到 2025 年,美國將有約 154,270 人被診斷出患有結直腸癌,這一數據凸顯了造口手術的必要性以及由此帶來的對造口管理解決方案日益成長的需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 6.7243億美元 |
| 市場規模:2031年 | 1,006,870,000 美元 |
| 複合年成長率:2026-2031年 | 6.96% |
| 成長最快的細分市場 | 可打開/可排水袋 |
| 最大的市場 | 北美洲 |
市場成長的主要障礙是造口皮膚併發症的高發生率。這些併發症常常導致產品誤用或停用,需要進一步的醫療干預,並加重健保報銷系統的負擔。此外,新興經濟體缺乏專業的造口護理人員,限制了適當管理系統的有效實施,並阻礙了整體市場擴張。
造口口袋系統的技術創新和感測器整合正透過滿足與防漏和皮膚健康相關的關鍵需求,對市場產生重大影響。製造商正投入資源研發先進的黏合劑配方和數位洩漏偵測技術,以便在潛在故障發生前提前警告患者。這些改進增強了患者的信心,並透過高級產品的普及推動了替換產品的銷售,這一趨勢也反映在主要行業參與者的財務表現中。例如,根據科樂普公司於2025年8月發布的“2024/25會計年度第三季中期財務報告”,該公司造口護理業務實現了6%的內部成長,這主要得益於區域銷售額的成長以及產品線更新帶來的商業化。
大腸直腸癌和發炎性腸道疾病發生率的不斷上升是推動造口造口數量成長的主要人口因素。人口老化以及這些疾病在年輕人群中的增加,導致結腸造口術、迴腸造口術和尿液引流的需求不斷成長,直接擴大了造口護理耗材的使用者群體。近期統計數據也印證了這種持續的臨床需求。根據Healthing.ca網站2025年9月發表的題為《加拿大結直腸癌:統計數據、影響和資源》的報導,加拿大每天約有66人被診斷出患有大腸直腸癌。病患的持續湧入為醫療設備製造商帶來了可觀的收入,康維特集團旗下Placi公司在2025會計年度上半年的造口護理業務收入達到3.27億美元便證明了這一點。
造造口皮膚併發症的發生對全球造口護理市場的財務成長構成重大結構性障礙。這些不良狀況,例如造口周圍的刺激和感染,會導致患者停止使用某些產品以尋找合適的設備,從而中斷持續的收入來源,並需要增加對客戶支援和退貨處理的投資。此外,治療這些可預防的皮膚問題所帶來的經濟負擔也給醫療保險報銷系統帶來了壓力。因此,支付方傾向於實施更嚴格的保險覆蓋範圍限制,並協商更低的採購價格以降低成本,從而擠壓市場參與企業的利潤空間。
既定的護理通訊協定與患者實際操作能力之間的差距,進一步加劇了這項挑戰,並直接影響併發症的發生率。根據美國造口協會聯合會2024年的數據,僅有55.1%的患者表示曾收到關於造口護理治療標準的教育資料。這種指導不足導致產品誤用普遍存在,併發症率上升。因此,醫療資源被轉移到糾正性維護而非引進先進產品上,最終減緩了整個市場的成長動能。
隨著製造商將環境責任置於優先地位並積極響應全球綠色舉措,開發永續且可生物分解的造口解決方案正成為關鍵趨勢。企業正日益摒棄傳統的生產方式,轉而採用循環製造程序,以最大限度地減少工業廢棄物和碳足跡。這一轉變意味著最佳化材料生命週期,實現產品再利用而非丟棄,使這些產品對具有環保意識的醫療保健系統更具吸引力。根據科樂普公司於2025年11月發布的2024/25會計年度年度報告,這項措施使公司生產廢棄物的回收率提升至83%,顯著超過了其該會計年度的永續性目標。
同時,針對不規則造口的軟凸面解決方案的普及,正在改變患者照護,它無需完全依賴數位技術,即可應對複雜腹部輪廓帶來的物理挑戰。與基於感測器的警報系統不同,軟凸面技術能夠即時適應回縮或扁平的造口,並透過結構柔軟性確保密封牢固。這種方法透過增加底盤與皮膚之間的物理接觸面積來降低滲漏風險,從而直接推動了對這些專用設備的需求。康維德集團(ConvaTec Group Plus)2025年2月發布的「截至2024年12月31日會計年度的初步商業性業績」顯示,其造口護理部門的有機銷售額成長了5.3%,這主要歸功於其「Esteem Body」軟凸面產品線的成功上市,這充分體現了這些解決方案的商業成功。
The Global Stoma Care Market is projected to expand from USD 672.43 Million in 2025 to USD 1006.87 Million by 2031, registering a CAGR of 6.96%. This market comprises medical devices, including ostomy bags and skin barriers, intended to manage waste output for patients who have undergone ostomy surgery. Key drivers fueling this market include the growing prevalence of colorectal cancer and inflammatory bowel disease, alongside an aging population that necessitates surgical intervention. According to the American Cancer Society, an estimated 154,270 individuals in the United States will be diagnosed with colorectal cancer in 2025, a statistic that underscores the need for surgeries resulting in stoma creation and the subsequent demand for management solutions.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 672.43 Million |
| Market Size 2031 | USD 1006.87 Million |
| CAGR 2026-2031 | 6.96% |
| Fastest Growing Segment | Open/Drainable Bags |
| Largest Market | North America |
A major hurdle hindering market growth is the frequency of peristomal skin complications, which result in patient discomfort and increased healthcare costs. These complications often cause product misuse or discontinuation, necessitating further medical attention that places a strain on reimbursement systems. Furthermore, the shortage of specialized stoma care nursing in emerging economies limits the effective implementation of appropriate management systems, thereby impeding the overall expansion of the market.
Market Driver
Technological innovations in ostomy pouching systems and sensor integration are heavily influencing the market by addressing critical needs regarding leak prevention and skin health. Manufacturers are dedicating resources to advanced adhesive formulations and digital leak-detection technologies that warn patients of potential failures before they happen. These improvements boost patient confidence and stimulate replacement sales through the adoption of premium products, a trend reflected in the financial results of major industry players. For instance, Coloplast's 'Interim Financial Report, 9M 2024/25' from August 2025 reports that their Ostomy Care business achieved 6% organic growth, driven by regional gains and the commercialization of updated product lines.
The increasing incidence of colorectal cancer and inflammatory bowel diseases acts as the primary demographic force driving the volume of surgical stoma creations. As these conditions become more prevalent among aging populations and younger adults, the requirement for colostomy, ileostomy, and urostomy procedures grows, directly expanding the user base for stoma care consumables. This sustained clinical demand is highlighted by recent statistics; a September 2025 article by Healthing.ca titled 'Colorectal cancer in Canada: Stats, impact and resources' notes that approximately 66 people are diagnosed with colorectal cancer daily in Canada. This consistent patient inflow supports revenue streams for medical device companies, as evidenced by Convatec Group Plc reporting Ostomy Care revenue of $327 million in the first half of 2025.
Market Challenge
The occurrence of peristomal skin complications serves as a significant structural barrier to the financial growth of the Global Stoma Care Market. These adverse conditions, such as irritation and infection near the stoma, frequently lead patients to discontinue specific products in their search for compatible appliances, thereby disrupting recurring revenue streams and necessitating increased investment in customer support and returns. Moreover, the economic burden of treating these preventable skin issues places heavy pressure on healthcare reimbursement systems. Consequently, payers are more inclined to enforce stricter coverage limitations or negotiate lower procurement prices to mitigate costs, which subsequently compresses the profit margins of market participants.
This challenge is further complicated by a gap between prescribed care protocols and actual patient proficiency, which directly contributes to complication rates. Data from the United Ostomy Associations of America in 2024 indicated that only 55.1% of patients reported receiving educational materials specific to ostomy care regarding their treatment standards. This lack of adequate instruction results in widespread product misuse and higher complication rates, forcing healthcare resources toward corrective maintenance rather than the adoption of advanced products, ultimately slowing the market's overall growth trajectory.
Market Trends
The development of sustainable and biodegradable ostomy solutions is emerging as a vital trend as manufacturers align with global green initiatives by prioritizing environmental responsibility. Companies are increasingly shifting away from traditional production methods in favor of circular manufacturing processes designed to minimize industrial waste and carbon footprints. This transition involves optimizing material lifecycles to repurpose production byproducts rather than discarding them, making these products more attractive to environmentally conscious healthcare systems. According to Coloplast's 'Annual Report 2024/25' from November 2025, this commitment led to an increase in their production waste recycling rate to 83%, significantly exceeding their fiscal year sustainability targets.
Simultaneously, the growing adoption of soft convexity solutions for irregular stomas is transforming patient care by addressing the physical challenges of complex abdominal contours without solely relying on digital technology. Unlike sensor-based alarms, soft convexity innovations offer immediate anatomical adaptation for retracted or flush stomas, securing a seal through structural flexibility. This approach reduces leakage risks by enhancing the physical interface between the wafer and the skin, directly driving demand for these specialized appliances. The commercial success of such solutions is evident in Convatec Group Plc's February 2025 'Preliminary results for the year ended 31 December 2024,' where the Ostomy Care division reported 5.3% organic revenue growth, largely attributed to the successful launch of the Esteem Body soft convex range.
Report Scope
In this report, the Global Stoma Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Stoma Care Market.
Global Stoma Care Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: